(2018) Evaluation of the efficacy and safety of beta-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial. International Immunopharmacology. pp. 112-117. ISSN 1878-1705 (Electronic) 1567-5769 (Linking)

(2018) Oral administration effects of beta-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. pp. 495-500. ISSN 1950-6007 (Electronic) 0753-3322 (Linking)